Takeda Pharmaceutical
TAK
#496
Rank
HK$367.63 B
Marketcap
HK$110.47
Share price
0.14%
Change (1 day)
5.74%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2025 (TTM): HK$4.40

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$4.37. a decrease over its 2024 EPS that were of HK$2.37.

EPS history for Takeda Pharmaceutical from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$1.77-25.03%
2024HK$2.37-60.3%
2023HK$5.9626.77%
2022HK$4.70-44.4%
2021HK$8.45722.5%
2020HK$1.03-79.14%
2019HK$4.93-43.73%
2018HK$8.7670.24%
2017HK$5.1445.47%
2016HK$3.54-158.86%
2015-HK$6.01-217.99%
2014HK$5.09-34.43%
2013HK$7.775.17%
2012HK$7.38-49.61%
2011HK$14.65-6.27%
2010HK$15.6336.82%
2009HK$11.43-28.28%
2008HK$15.9324.96%
2007HK$12.759.24%
2006HK$11.673.21%
2005HK$11.31-6.29%
2004HK$12.0718.8%
2003HK$10.1630.39%
2002HK$7.7952.45%
2001HK$5.111.77%
2000HK$5.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.22 1,759.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.83 560.22%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$13.38 206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.26 1,211.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-HK$31.20-814.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.34 45.11%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$101.37 2,221.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.98 540.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$59.08 1,252.93%๐Ÿ‡บ๐Ÿ‡ธ USA